Barr Foresees Plan B OTC Launch In The Fall Pending “Approvable” Status

Barr Labs expects its Plan B (levonorgestrel) emergency contraceptive to hit the market as an OTC by September at the earliest, assuming FDA says the product is approvable by the May 21 PDUFA deadline